Europe
Changes announced to executive team to accelerate growth and strategy
Novo REPAIR Impact Fund to invest up to CHF 11.5M in Polyphor’s antibiotic OMPTA pipeline through a CHF 6.8M equity investment, as well as a potential additional CHF 4.7M investment against program-specific royalties
MorphoSys AG announced today that its shares will be included in the MDAX as of September 24, 2018 as announced by Deutsche Börse.
Arecor has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes.
Tecan is offering its customers unprecedented insight into how their Fluent® and Freedom EVO® liquid handing platforms are being used, thanks to its Introspect™ and Common Notification System (Tecan CNS™) software tools.
Medigene AG today announced its participation at the following upcoming investor and scientific conferences:
Vectura regaining momentum with continued inhaled revenue and adjusted EBITDA growth
Partnership combines Intellegens’ proprietary AI technology withOptibrium’s expertise in predictive modelling and compound design
Expedeon AG today announced the signing of a licence and supply agreement for its colloidal gold with South Korea-based PaxGenBio, a privately held, independent developer and supplier of rapid, highly sensitive multiplex diagnostic kits.
Crescendo Biologics Ltd today announces that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect.
PRESS RELEASES